An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Researchers and reviewers took a close look at a class of drugs called "growth hormone secretagogues" — that just means compounds that make the body release more growth hormone. The article traces where these compounds came from, how they work in the body, and how far they've gotten in testing for medical use. It’s essentially a status update: the science behind them, what they can do, and what’s still experimental. Growth hormone secretagogues include several different molecules. Some are small proteins called peptides, and others are small synthetic drugs. They act on a specific target in the brain and pituitary gland (the part of your body that controls growth hormone) to tell it to release more growth hormone. One well-known example is ghrelin, a natural hormone often nicknamed the “hunger hormone”; some secretagogues mimic ghrelin’s effect. In plain terms, these drugs either copy or stimulate the body's own signals that prompt the pituitary gland to produce growth hormone. The review summarizes many studies, from early lab experiments to clinical trials in humans. In animals and early human trials, some of these compounds reliably increased growth hormone levels for a time. But effects on real-world outcomes — things people care about, like muscle strength, bone density, physical function, or long-term health — are smaller and less consistently proven. Some studies were short and small, so the results are preliminary. A handful of compounds advanced into clinical testing for conditions like growth hormone deficiency, muscle wasting, or age-related decline, but few have become approved medicines with clear, proven benefits. Why should a regular person care? Growth hormone affects muscle, bone, fat distribution, and metabolism. If safe and effective secretagogues were available, they might help people with medical conditions that cause low growth hormone — for example, certain pituitary disorders, muscle wasting from chronic illness, or specific age-related declines. They are not weight-loss miracle drugs, and they’re not the same as the hormones athletes might misuse. For most healthy people, there’s no clear benefit and uncertain risks. There are important caveats. Increasing growth hormone can have downsides: joint pain, swelling, insulin resistance (which can affect blood sugar), and potentially increasing the growth of unwanted tissues like tumors — those risks are why regulators are cautious. Many secretagogues are still experimental and not approved for general use; dosing, long-term safety, and who benefits most are not fully established. People with certain cancers, diabetes, or active health problems should be especially cautious. Always rely on approved treatments and a doctor’s advice rather than experimental compounds. Bottom line: growth hormone secretagogues are promising in some medical contexts, but the evidence is mixed and safety questions remain, so they’re not ready as general-use treatments.
Source: Wiley Online Library